Patents
Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
09/2009
09/03/2009CA2709863A1 Azetidine derivatives, their preparation and their application in therapy
09/02/2009EP1794129A4 Synthesis by chiral diamine-mediated asymmetric alkylation
09/02/2009EP1470137B1 Edg receptor agonists
08/2009
08/27/2009WO2009105440A1 Beta-lactams for reducing intraocular pressure
08/27/2009WO2009103883A1 Method for preparing azetidine derivatives
08/27/2009WO2008135819A8 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide
08/27/2009US20090216009 Process for the production of ezetimibe and intermediates used in this process
08/26/2009EP2091915A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties
08/26/2009CN101516867A Aryl sulfonamides with an analgesic action
08/25/2009US7579339 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/19/2009CN100528842C Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
08/18/2009US7576200 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
08/18/2009US7576131 Administering 2-acetamidoethyl 4-chlorophenyl-(3-trifluoro-methylphenoxy)acetate, as antidiabetic agents
08/18/2009US7575890 Method for rapid detection and evaluation of cultured cell growth
08/13/2009US20090203663 Chemical compounds
08/13/2009US20090203578 Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use
08/12/2009CN101506155A Biphenyl derivatives and their use in treating hepatitis C
08/12/2009CN101506140A Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
08/11/2009US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide
08/11/2009US7572792 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction
08/11/2009CA2527933C Substituted 3-alkyl and 3-alkenyl azetidine derivatives
08/06/2009US20090197861 Inhibitors of integrin alpha2beta1 with modified urea moiety
08/06/2009US20090197857 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
08/05/2009EP1781606B1 Azetidine derivatives as ccr-3 receptor antagonists
08/05/2009CN101500992A Method for producing 1-methylcarbapenem production intermediate
08/05/2009CN100522159C The use of substituted azetidinone compounds for the treatment of sitosterolemia
07/2009
07/29/2009EP1461315B1 Catalytic carbonylation of three and four membered heterocycles
07/23/2009WO2009091764A2 Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss
07/23/2009WO2009038759A3 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders
07/23/2009US20090186866 Therapeutic beta-lactams
07/23/2009US20090186834 Diphenylheterocycle cholesterol absorption inhibitors
07/23/2009DE102007054497B3 New crystalline hydrate form of dodecanedioic acid 4-((2S,3R)-3-((S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl)-2-(4-methoxy- phenyl)-4-oxo-azetidin-1-yl)-benzylamide ((2S,3R,4R,5R)-pentahydroxy- hexyl)-amide useful e.g. to treat hyperlipidemia
07/23/2009CA2712264A1 Therapeutic beta-lactams
07/22/2009EP1458413B1 Pharmaceutical compositions based on azetidine derivatives
07/21/2009US7563888 Process for the preparation of diphenyl azetidinone derivatives
07/16/2009US20090181939 Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated Disorders
07/15/2009CN101481345A Spirocyclic-beta-lactam 1-alkyl-2,7- dioxo-1- azaspiro [3.5]- nonane-5,8-diene-3-substituted carboxylic ether and preparation thereof
07/14/2009US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR)
07/09/2009US20090176782 Inhibitors of tace
07/08/2009EP1843767B1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders.
07/08/2009CN101479240A Diphenylazetidinone derivates possessing cholesterol absortion inhibitor activity
07/08/2009CN101475521A Method for synthesizing acetate of 1-benzhydryl-3-azetidine amidino acetic ester
07/08/2009CN100509781C Method for producing 1,4-diphenyl azetidinone derivatives
07/02/2009WO2009080335A1 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
07/02/2009US20090170824 Diarylsulfones as 5-HT2A Antagonists
07/02/2009CA2710447A1 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
07/01/2009EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor
07/01/2009CN101472886A Substituted phenyl methanone derivatives
07/01/2009CN100506792C Substituted N-arylheterocycles, method for production and use thereof as medicaments
07/01/2009CN100506776C NK1 antagonists
06/2009
06/30/2009US7553989 Such as monoacetyloxymethyl malonate; for use in production of prodrug-type carbapenem antibacterial agents for oral administration; cost efficiency
06/25/2009US20090163466 Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
06/25/2009DE102007063671A1 Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New crystalline Diphenylazetidinonhydrate, pharmaceutical compositions containing them and their use
06/24/2009CN101466667A Azetidine derivatives as g-protein coupled receptor (GPR119) agonists
06/24/2009CN101462995A Method for preparing 4-alkynyl azetidin-2-one
06/24/2009CN100503560C Substituted cyclohexane derivatives
06/23/2009CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/18/2009WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors
06/18/2009WO2009015485A8 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
06/18/2009US20090156576 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
06/18/2009CA2706679A1 Novel compounds 010
06/17/2009CN101456836A Method for preparing 4-propargyl nitrogen heterocyclic butyl-2-one and 4-allenyl nitrogen heterocyclic butyl-2-one
06/10/2009EP2066626A1 Azetidine derivatives as muscarinic receptor antagonists
06/09/2009US7544667 Hypocholesterolemic compounds
06/09/2009CA2162900C New peptide derivatives
06/04/2009WO2009067960A2 A method of manufacturing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)-3- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone and its intermediates
06/04/2009US20090143351 Substituted azetidinones
06/03/2009EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
06/02/2009US7541458 forming cis- and trans- 3-trimethylsilyloxy beta-lactam; convert cis- to cis-N-t-butoxycarbonyl-3-trimethylsilyloxy-4-phenyl-azetidin-2-one; chemical synthesis in one pot process at high temperature; use as synthetic intermediates for a variety of other biologically active compounds
05/2009
05/28/2009US20090137546 Anti-Hypercholesterolemic Compounds
05/27/2009EP2061779A1 Aryl sulfonamides with an analgesic action
05/27/2009CN101440057A Chloridization method for nitrogen heterocyclic butanone isobutene derivatives
05/27/2009CN101440056A Method for splitting docetaxel side chain intermediate
05/26/2009US7538212 Intermediate for carbapenem compound for oral administration and process for producing the same
05/22/2009WO2009062619A1 New crystalline diphenyl acetidinone hydrate, pharmaceutical agent containing said compound and use thereof
05/21/2009US20090131395 Biphenylazetidinone cholesterol absorption inhibitors
05/19/2009CA2468879C Substituted cyclohexane derivatives
05/14/2009WO2009061652A1 Compounds which modulate the cb2 receptor
05/14/2009US20090124786 Pyroglutamic Acid Esters With Improved Biodegradility
05/14/2009DE102007052900A1 Stereospezifische Hydroxylierung Stereospecific hydroxylation
05/14/2009CA2704684A1 Compounds which modulate the cb2 receptor
05/13/2009EP1562927B1 Thio-analogues of paclitaxel and intermediates thereof
05/13/2009CN101429155A Azacyclo-amino substituted tetracycline derivant
05/13/2009CN100486964C Process of synthesizing (2S-trans)-3-methyl-4-oxo-1-azacyclo butyl sulfonic acid
05/12/2009US7531657 Reacting compounds such as S)-3-benzyloxycarbonylamino-2-piperidone with a sililating agent, subsequently reacting it with a phosphorus oxyhalide , reacting with ammonia to produce compounds such as S)-3-benzyloxycarbonylamino-1-diaminophosphinyl-2-piperidone
05/07/2009US20090118160 Heterocyclic compounds and methods of use
05/06/2009EP2055696A1 Acid addition salts of mandelic acid derivatives
05/06/2009EP2054368A2 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
05/06/2009CN101426771A Process for manufacturing diazepine derivatives
05/06/2009CN101423511A Ezetimible intermediate and synthetic method of ezetimible
04/2009
04/30/2009WO2009054887A1 Process for preparing an anti-hypercholesterolemic compound
04/29/2009CN101421234A Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
04/23/2009WO2009051244A1 Heterocyclic compound
04/21/2009US7521552 Process for preparation of substituted amino alcohols
04/16/2009US20090099355 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids
04/15/2009EP1720550B1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
04/15/2009CN101407486A Process for synthesizing 4- acetoxy-2-azetidinone
04/15/2009CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof
04/14/2009US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof
04/09/2009WO2009045419A1 Novel azetidinones useful as inhibitors of elastase
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 69